CESARO, ARTURO
 Distribuzione geografica
Continente #
EU - Europa 151
NA - Nord America 10
AS - Asia 8
AF - Africa 1
Totale 170
Nazione #
IT - Italia 99
FR - Francia 36
US - Stati Uniti d'America 9
CZ - Repubblica Ceca 6
IE - Irlanda 6
IN - India 3
SG - Singapore 3
UA - Ucraina 2
VN - Vietnam 2
CA - Canada 1
GB - Regno Unito 1
NG - Nigeria 1
NL - Olanda 1
Totale 170
Città #
Naples 20
Bergamo 7
Dublin 6
Castenaso 3
Singapore 3
Bolzano Vicentino 2
Council Bluffs 2
Marsala 2
Rome 2
Varese 2
Bengaluru 1
Columbus 1
Dong Ket 1
Indore 1
Lagos 1
Livorno 1
London 1
Los Angeles 1
Lucca 1
Maranello 1
Milan 1
Mumbai 1
Muskegon 1
New Orleans 1
Noisy-le-grand 1
Sordio 1
Toronto 1
Wilmington 1
Totale 67
Nome #
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study, file dfd1c04d-a2e9-0799-e053-6605fe0a8ddb 20
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry, file dfd1c04d-c45b-0799-e053-6605fe0a8ddb 9
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease, file dfd1c04d-bdfa-0799-e053-6605fe0a8ddb 8
Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention, file 414f35e6-04c3-4410-8c80-e45f4627fb6c 6
ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial, file dfd1c04d-088f-0799-e053-6605fe0a8ddb 6
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies, file dfd1c04d-b5b3-0799-e053-6605fe0a8ddb 6
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge, file dfd1c04d-c4fa-0799-e053-6605fe0a8ddb 6
Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence, file dfd1c04d-e506-0799-e053-6605fe0a8ddb 6
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry), file dfd1c04d-f170-0799-e053-6605fe0a8ddb 6
Dietary thiols: A potential supporting strategy against oxidative stress in heart failure and muscular damage during sports activity, file dfd1c04d-7700-0799-e053-6605fe0a8ddb 5
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia, file dfd1c04d-c0d2-0799-e053-6605fe0a8ddb 5
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry, file dfd1c04d-feca-0799-e053-6605fe0a8ddb 5
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT), file 29043657-aee0-4e5b-983e-9902065297b6 4
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study, file a2ef4b41-7e63-445f-9c62-78fe9004b140 4
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study, file dfd1c04d-39c6-0799-e053-6605fe0a8ddb 4
Exercise, immune system, nutrition, respiratory and cardiovascular diseases during COVID-19: A complex combination, file dfd1c04d-710a-0799-e053-6605fe0a8ddb 4
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy, file dfd1c04d-b5a9-0799-e053-6605fe0a8ddb 4
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience, file dfd1c04b-e511-0799-e053-6605fe0a8ddb 3
Letter by Calabrò et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)", file dfd1c04c-185e-0799-e053-6605fe0a8ddb 3
Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future?, file dfd1c04c-36cb-0799-e053-6605fe0a8ddb 3
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease, file dfd1c04d-40dc-0799-e053-6605fe0a8ddb 3
Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve, file dfd1c04d-a630-0799-e053-6605fe0a8ddb 3
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects, file dfd1c04d-b330-0799-e053-6605fe0a8ddb 3
Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk, file dfd1c04d-d6d0-0799-e053-6605fe0a8ddb 3
Improving adherence to Ticagrelor in patients after acute coronary syndrome: Results from the PROGRESS trial, file dfd1c04d-fc08-0799-e053-6605fe0a8ddb 3
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry, file ef6d6c5d-480f-45ed-a7df-adc263f91fcf 3
New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention, file 8b703d8a-5e23-4d1f-9384-50a4a8d232e8 2
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology, file bb104d05-bf9c-4630-937a-f74b07366b36 2
Left atrial and auricular thrombosis in patients with atrial fibrillation: from pathophysiology to treatment, file dfd1c04c-7664-0799-e053-6605fe0a8ddb 2
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy, file dfd1c04c-e958-0799-e053-6605fe0a8ddb 2
Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target, file dfd1c04d-a72d-0799-e053-6605fe0a8ddb 2
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease, file dfd1c04d-c0c1-0799-e053-6605fe0a8ddb 2
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry, file dfd1c04d-d5e4-0799-e053-6605fe0a8ddb 2
Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy, file dfd1c04d-d778-0799-e053-6605fe0a8ddb 2
Improving adherence to Ticagrelor in patients after acute coronary syndrome: Results from the PROGRESS trial, file dfd1c04d-fecc-0799-e053-6605fe0a8ddb 2
Von Willebrand Factor as a Novel Player in Valvular Heart Disease: From Bench to Valve Replacement, file dfd1c04b-9719-0799-e053-6605fe0a8ddb 1
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience, file dfd1c04b-e38d-0799-e053-6605fe0a8ddb 1
Laboratory medicine: health evaluation in elite athletes, file dfd1c04c-6645-0799-e053-6605fe0a8ddb 1
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition, file dfd1c04c-e7bf-0799-e053-6605fe0a8ddb 1
Cardiac involvement in systemic sclerosis: 'early diagnosis-early management' approach, file dfd1c04d-0e7d-0799-e053-6605fe0a8ddb 1
Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?, file dfd1c04d-711d-0799-e053-6605fe0a8ddb 1
Rheumatic mitral stenosis in a 28-week pregnant woman treated by mitral valvuoplasty guided by low dose of radiation: a case report and brief overview, file dfd1c04d-7251-0799-e053-6605fe0a8ddb 1
Childhood obesity: An overview of laboratory medicine, exercise and microbiome, file dfd1c04d-72dc-0799-e053-6605fe0a8ddb 1
Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis, file dfd1c04d-7929-0799-e053-6605fe0a8ddb 1
Coronary stent thickness: thinner is (always) better for all lesions?, file dfd1c04d-7bb6-0799-e053-6605fe0a8ddb 1
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry, file dfd1c04d-a30d-0799-e053-6605fe0a8ddb 1
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence, file dfd1c04d-b26c-0799-e053-6605fe0a8ddb 1
Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter, file dfd1c04d-d652-0799-e053-6605fe0a8ddb 1
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism, file dfd1c04d-d73a-0799-e053-6605fe0a8ddb 1
Methicillin-resistant staphylococcus aureus: Risk for general infection and endocarditis among athletes, file dfd1c04d-e508-0799-e053-6605fe0a8ddb 1
Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease, file dfd1c04d-f2c2-0799-e053-6605fe0a8ddb 1
Transradial access versus transfemoral access: a comparison of outcomes and efficacy in reducing hemorrhagic events, file dfd1c04d-fc07-0799-e053-6605fe0a8ddb 1
Totale 170
Categoria #
all - tutte 654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 2 0 0 0
2020/202130 0 0 0 0 0 0 1 0 4 3 0 22
2021/202264 0 0 0 0 1 0 1 37 4 0 20 1
2022/202348 0 0 1 5 4 6 8 15 8 0 1 0
2023/202426 2 4 3 1 3 0 3 0 2 8 0 0
Totale 170